drugset / Trial / NCT01897324

IVF/ICSI Protocols in Poor Responders With Growth Hormone

NCT01897324

Phase 4 Completed 287 enrolled Woman's Health University Hospital, Egypt
RandomizedParallel-groupOpen-labelTreatment

Summary

in this study, we are trying to monitor the effect of the addition of growth hormone on the different down regulation protocols ( long, short, antagonist and microflare). The outcome will be primarily assessed by the clinical pregnancy rates.

Timeline

Start
2013-07
Primary completion
2015-01
Completion
2015-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Somatropin Protein / enzyme biologic 2.5 mg Subcutaneous

Indications